Consumer Discretionary • Catalog/Specialty Distribution
$58.38 ▼ -2.24
(-3.69%)
MKT CAP: $2.16B • VOL: 902.1K
52W L $25 52W H $62
GCT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.29B | $1.16B | $703.8M |
| YoY Revenue Growth % | +11.1% | +65.0% | — |
| Gross Profit | $300.7M | $285.2M | — |
| Gross Margin % | 23.3% | 24.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $145.0M | $130.6M | $110.1M |
| Operating Margin % | 11.2% | 11.3% | 15.6% |
| Net Income (GAAP) | $137.4M | $125.8M | $94.1M |
| EBITDA (Normalized) | $151.3M | $143.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $190.7M | $158.1M | $133.5M |
| Capital Expenditures (CapEx) | $7.9M | $15.5M | — |
| Free Cash Flow (FCF) | $182.8M | $142.5M | $133.5M |
| FCF Margin % | 14.2% | 12.3% | 19.0% |
| Return on Invested Capital (ROIC %) | 95.0% | 70.9% | — |
| Cash & Short-Term Equivalents | $379.8M | $259.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $485.8M | $405.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GCT.